Our artificial pancreas successfully tested at home

Article on performance and safety of Artificial Pancreas of Inreda Diabetic

May 13, 2016 – Inreda Diabetic is moving from development towards reality. Together with the Academic Medical Centre in Amsterdam and the Rijnstate hospital in Arnhem (The Netherlands), we’ve completed a clinical study with our artificial pancreas. The results are promising!

In the last years, we’ve built and tested several prototypes of our artificial pancreas. Step by step, our device became smaller, smarter, and more integrated (all-in-one). This allowed us to be able to run this pilot study in everyday life conditions, with 10 test subjects using our artificial pancreas for 4 days.

You can read the full article for free online (see below), but in a nutshell, there are 2 points worth attention:

  • During the study, our integrated artificial pancreas provided better glucose control than insulin pump therapy in patients with type 1 diabetes at home. Indeed, treatment with our bi-hormonal artificial pancreas ensured that the blood sugar levels remain within the normal values 85% of the time, compared to 69% when using the insulin pump. And considerably better results were achieved at night (that’s what indicates an analysis of the day and night values).
  • It proved that the treatment with our artificial pancreas is at least as safe as existing insulin pump therapy.
    Those promising results were achieved while our device was autonomously regulating the participants’ glucose level, and without having to ask the participants to enter carbohydrates values, inject insulin themselves (and calculating how much) etc…

Want to read the study in details? The results are published in a peer-reviewed international diabetes journal. It is open access, so the article is readable and downloadable on the website of the journal at:

With the completion of this pilot study, we continue heading towards commercialization of our product. One follow-up study is needed to obtain European certification (planned for the beginning of 2017).

Apart from the clinical data: the experience of our participants is essential to us.
How does it actually feel to wear an artificial pancreas? We did interviews with the participants right after the end of the trial, and we’ll just end that post by sharing some encouraging feedback:

“I felt myself more free. Not thinking all the time about eating, sporting etc. At one point, I ate something completely different, and you don’t need to think about it! You are less busy with it.”

“Actually… I don’t want to give it back!”


< Back to the news overview